Neurophet
Healthcare Software · South Korea · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Samwon Tower 124 Teheran-ro Gangnam-gu 1...Website
www.neurophet.comRevenue
$9.7 MillionIndustry
About Neurophet
Neurophet Org Chart
Is Neurophet your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Neurophet has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Neurophet recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Neurophet
Neurophet, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Neurophet has new funding data
Check out if Neurophet is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Click to see if Neurophet had a recent Job posting/layoffs
Product Launch: Get notified when Neurophet launches new products
Recommended Actions
Reach out to Masked Content who joined Neurophet as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Neurophet is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Neurophet is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Neurophet.
Neurophet Tech Stack
A closer look at the technologies used by Neurophet
Most Recent Scoops
Neurophet News & Media
Neurophet Supplies 'Neurophet AQUA' and 'Neurophet AQUA AD Plus' to Elevate Clinic in the U.S., Expanding Its Presence in the U.S. Brain Disorders Market
Provides solutions for analyzing brain atrophy and white matter hyperintensities, as well as monitoring side effects associated with Alzheimer's disease treatments Secures a key reference site at a U.S. medical institution specializing in neurological disorders, accelerating product...Neurophet Showcases 'Neurophet AQUA AD Plus' at AAIC 2026, Expands Global Partnerships
Showcasing AI-powered brain imaging analysis solutions, including Neurophet AQUA and Neurophet SCALE PET Engaging in partnering meetings with global pharmaceutical companies and CROs to accelerate business development in the ICL sector SEOUL, South Korea, July 7, 2026 /PRNewswire/ --...Neurophet Supplies 'Neurophet AQUA' to Raffles Medical in Singapore
Providing Neurophet AQUA capable of analyzing brain atrophy and white matter degeneration… Securing meaningful clinical reference SEOUL, South Korea, July 2, 2026 /PRNewswire/ -- Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for...Neurophet Launches Joint Study with VHIR on 'Neurophet AQUA MS', Accelerating AI Algorithm Validation
Collaborative research on AI-based diagnosis of multiple sclerosis, Building a clinical trial dataset Leveraging large-scale, multi-center brain MRI datasets to detect key lesion biomarkers SEOUL, South Korea, May 26, 2026 /PRNewswire/ -- Neurophet (Co-CEOs Jake Junkil Been and Donghyeon...
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Neurophet
Founded in 2016, 뉴로핏 is a specialized company that develops brain imaging analysis solutions and therapeutic medical devices based on artificial intelligence (AI) technology. Their focus encompasses the entire cycle of diagnosis, treatment guidance, and therapy.... Read More